Shalby drops after weak Q3 outcome

Shalby lost 3.4% to Rs 256.90 at 10:51 IST on BSE after net profit dropped 50.9% to Rs 10.9 crore on 33.8% growth in total income to Rs 102 crore in Q3 December 2017 over Q3 December 2016.

The result was announced after trading hours yesterday, 9 January 2018.

Meanwhile, the S&P BSE Sensex was up 0.53 points to 34,443.72. The S&P BSE Small-Cap index was up 40.31 points, or 0.2%, to 19,951.48.

On BSE, so far 2.33 lakh shares were traded in the counter as against average daily volume of 2.27 lakh shares in the past two weeks. The stock hit a high of Rs 263.25 and a low of Rs 253 so far during the day. The stock had hit a record high of Rs 274 on 9 January 2018. The stock had hit a record low of Rs 210.15 on 28 December 2017.

The small-cap company has equity capital of Rs 108.01 crore. Face value per share is Rs 10.

Shares of Shalby had seen poor debut on the bourses on 15 December 2017. The stock listed at Rs 237 on BSE, a discount of 4.43% from the issue price of Rs 248 per share. The stock settled at Rs 239.25 on BSE, a discount of 3.53% from its issue price on its debut.

The initial public offer (IPO) of Shalby received bids for 4.08 crore shares, data on NSE showed. The IPO was subscribed 2.82 times. The price band of the IPO was Rs 245 to Rs 248 per share. The IPO opened for subscription on 5 December 2017 and closed on 7 December 2017.

Shalby is one of the leading multi-specialty chain of hospitals in India. Its hospitals are tertiary care hospitals, few of which also offer quaternary healthcare services to patients in various areas of specialization such as orthopedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations.

Powered by Capital Market - Live News